Thursday, October 19th | 29 Tishri 5778

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
June 14, 2017 11:22 am

21 Israeli Companies to Participate in World’s ‘Largest’ Biotech Conference

avatar by JNS.org

Email a copy of "21 Israeli Companies to Participate in World’s ‘Largest’ Biotech Conference" to a friend

A poster at a past BIO International Convention. Photo: YouTube screenshot.

JNS.org – Twenty-one leading Israeli companies will have a presence June 19-22 at the Israel Innovation Authority’s (IIA) pavilion during the 2017 BIO International Convention in San Diego, which is billed as the world’s “largest” biotech conference.

The Israeli Ministry of Economy called the conference the “world’s largest and most prestigious biotechnology event,” with more than 16,000 attendees from 76 countries convening to share ideas and insights on the latest biotechnology innovations.

Heads of state, government ministers, ambassadors and regulatory agencies attend the conference. This year’s keynote speaker is former British Prime Minister David Cameron.

The IIA has participated in the biotech convention for the past two decades, and during the past eight years has organized Israel’s national pavilion.

Related coverage

October 19, 2017 2:53 pm
0

Israeli Reps Exit Inter-Parliamentary Union Assembly After Muslim Harassment

JNS.org - In the wake of Israel announcing its withdrawal from United Nations cultural body UNESCO due to anti-Israel bias, Israeli...

“The conference is an opportunity for Israeli companies to present their latest developments, and create scientific and economic ties with leading international players in the field,” said Aharon Aharon, CEO of the IIA.

Some of the Israeli companies participating in the conference are Alpha Tau Medical, which utilizes alpha radiation to treat cancerous tumors; Body Vision Medical, which is revolutionizing early-stage diagnosis of tumors; and Nutrino Health, which utilizes digital monitoring to create nutrition plans for people with diabetes.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner

Algemeiner.com